On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.996903
Abstract: The loss of mobility is a common trait in multiple health conditions (e.g., Parkinson's disease) and is associated with reduced quality of life. In this context, being able to monitor mobility in the real world,… read more here.
Keywords: new drugs; mobility biomarkers; mobility; sensors mobility ... See more keywords